Recombinant factor VIIa for intracranial haemorrhage in a Jehovah’s Witness with severe haemophilia

A Jehovah’s Witness with severe haemophilia A and a high titre, high responding inhibitor to both human and porcine factor VIII (FVIII) was treated with recombinant activated factor VII (rVIIa) during an episode of intracranial bleeding. He recovered completely without any adverse effects or neurological sequelae.

Continue here

Advertisements
%d bloggers like this: